2 known cases. View patent page →
Reported but unconfirmed D.N.J. declaratory-judgment action by Acuitas against Arbutus and Genevant, challenging a list of patents including 11141378 and other Arbutus family patents. The narrative could not independently verify the case number 3:23-cv-04200 against the Acuitas caption.
Acuitas Therapeutics filed a declaratory judgment action in the Southern District of New York against Genevant Sciences GmbH and Arbutus Biopharma Corp., seeking non-infringement and invalidity of Arbutus patents including U.S. Patent No. 9,006,417, in connection with the Pfizer/BioNTech COVID-19 vaccine COMIRNATY and Acuitas's LNP technology. Acuitas voluntarily dismissed the action without prejudice on August 4, 2023, and it was terminated August 7, 2023, coinciding with refiling in New Jersey.